BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meier-Menches SM, Neuditschko B, Zappe K, Schaier M, Gerner MC, Schmetterer KG, Del Favero G, Bonsignore R, Cichna-Markl M, Koellensperger G, Casini A, Gerner C. An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells. Chemistry 2020;26:15528-37. [PMID: 32902006 DOI: 10.1002/chem.202003495] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Del Favero G, Zeugswetter M, Kiss E, Marko D. Endoplasmic Reticulum Adaptation and Autophagic Competence Shape Response to Fluid Shear Stress in T24 Bladder Cancer Cells. Front Pharmacol 2021;12:647350. [PMID: 34012396 DOI: 10.3389/fphar.2021.647350] [Reference Citation Analysis]
2 Annunziata A, Ferraro G, Cucciolito ME, Imbimbo P, Tuzi A, Monti DM, Merlino A, Ruffo F. Halo complexes of gold( i ) containing glycoconjugate carbene ligands: synthesis, characterization, cytotoxicity and interaction with proteins and DNA model systems. Dalton Trans . [DOI: 10.1039/d2dt00423b] [Reference Citation Analysis]
3 Ghini V, Senzacqua T, Massai L, Gamberi T, Messori L, Turano P. NMR reveals the metabolic changes induced by auranofin in A2780 cancer cells: evidence for glutathione dysregulation. Dalton Trans 2021;50:6349-55. [PMID: 33885689 DOI: 10.1039/d1dt00750e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wan PK, Tong KC, Lok CN, Zhang C, Chang XY, Sze KH, Wong AST, Che CM. Platinum(II) N-heterocyclic carbene complexes arrest metastatic tumor growth. Proc Natl Acad Sci U S A 2021;118:e2025806118. [PMID: 33883283 DOI: 10.1073/pnas.2025806118] [Reference Citation Analysis]
5 van der Westhuizen D, Slabber CA, Fernandes MA, Joubert DF, Kleinhans G, van der Westhuizen CJ, Stander A, Munro OQ, Bezuidenhout DI. A Cytotoxic Bis(1,2,3-triazol-5-ylidene)carbazolide Gold(III) Complex Targets DNA by Partial Intercalation. Chemistry 2021;27:8295-307. [PMID: 33822431 DOI: 10.1002/chem.202100598] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Safir Filho M, Scattolin T, Dao P, Tzouras NV, Benhida R, Saab M, Van Hecke K, Lippmann P, Martin AR, Ott I, Nolan SP. Straightforward synthetic route to gold( i )-thiolato glycoconjugate complexes bearing NHC ligands (NHC = N-heterocyclic carbene) and their promising anticancer activity. New J Chem 2021;45:9995-10001. [DOI: 10.1039/d1nj02117f] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Meier-Menches SM, Neuditschko B, Zappe K, Schaier M, Gerner MC, Schmetterer KG, Del Favero G, Bonsignore R, Cichna-Markl M, Koellensperger G, Casini A, Gerner C. An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells. Chemistry 2020;26:15528-37. [PMID: 32902006 DOI: 10.1002/chem.202003495] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
8 van der Westhuizen D, Bezuidenhout DI, Munro OQ. Cancer molecular biology and strategies for the design of cytotoxic gold(I) and gold(III) complexes: a tutorial review. Dalton Trans 2021. [PMID: 34693422 DOI: 10.1039/d1dt02783b] [Reference Citation Analysis]
9 Gallati CM, Goetzfried SK, Ortmeier A, Sagasser J, Wurst K, Hermann M, Baecker D, Kircher B, Gust R. Synthesis, characterization and biological activity of bis[3-ethyl-4-aryl-5-(2-methoxypyridin-5-yl)-1-propyl-1,3-dihydro-2H-imidazol-2-ylidene]gold(i) complexes. Dalton Trans 2021;50:4270-9. [PMID: 33688890 DOI: 10.1039/d0dt03902k] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kakoulidou C, Kosmas VR, Hatzidimitriou AG, Fylaktakidou KC, Psomas G. Structure and biological profile of transition metal complexes with (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline. J Inorg Biochem 2021;219:111448. [PMID: 33853005 DOI: 10.1016/j.jinorgbio.2021.111448] [Reference Citation Analysis]
11 Jarosz M, Keppler BK, Timerbaev AR. Current and emerging mass spectrometry methods for the preclinical development of metal-based drugs: a critical appraisal. Anal Bioanal Chem 2021. [PMID: 34642780 DOI: 10.1007/s00216-021-03718-5] [Reference Citation Analysis]
12 Lu Y, Ma X, Chang X, Liang Z, Lv L, Shan M, Lu Q, Wen Z, Gust R, Liu W. Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases. Chem Soc Rev 2022. [PMID: 35699475 DOI: 10.1039/d1cs00933h] [Reference Citation Analysis]